Results 121 to 130 of about 775,328 (297)

Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia. [PDF]

, 2009
We observed that high-dose methylprednisolone (HDMP) and rituximab was well tolerated and had promising activity when used in combination to treat patients with fludarabine-refractory chronic lymphocytic leukemia (CLL).
Bole, J, Castro, JE, Jain, S, James, DF, Kipps, TJ, Rassenti, L, Sandoval-Sus, JD   +6 more
core  

A geometrically controlled rigidity transition in a model for confluent 3D tissues

, 2017
The origin of rigidity in disordered materials is an outstanding open problem in statistical physics. Previously, a class of 2D cellular models has been shown to undergo a rigidity transition controlled by a mechanical parameter that specifies cell ...
Manning, Lisa, Merkel, Matthias
core   +1 more source

Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenetic response after interferon-alpha results in any high complete molecular response. [PDF]

, 2008
To determine the impact on minimal residual disease by switching to imatinib chronic phase chronic myeloid leukaemia (CP-CML) patients responsive to interferon-alpha (IFNα), in stable complete cytogenetic response (CCR) but with persistent PCR positivity.
B. De Angelis, B. Rotoli, D. Divero, F. Mandelli, F. P.a.n.e., F. Quarantelli, G. Alimena, I. Carmosino, IZZO, BARBARA, L. Luciano, M. Breccia, M. Mancini, N. Nanni, PICARDI, MARCO, R. La tagliata   +14 more
core   +1 more source

13 Real-world tissue-based circulating tumor DNA (ctDNA) minimal residual disease (MRD) assay predicts outcome in lung cancer patients who had curative treatments [PDF]

, 2022
Youjin Oh, Liam Il‐Young Chung, Soowon Lee, Timothy Hong, Leesul Kim, Sung Mi Yoon, Joo Hee Park, Trie Arni Djunadi, Young Kwang Chae   +8 more
openalex   +1 more source

Assessment of minimal residual disease in childhood acute lymphoblastic leukemia

Journal of Applied Hematology, 2016
The improving cure rate of childhood acute lymphoblastic leukemia (cALL) is considered as success story in the field of oncology. It has become possible due to progressive refinement of treatment over the period of years.
Sonia K Parikh, Urmila P Uparkar
doaj   +1 more source

Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

Leukemia, 2017
Flow cytometry has become a highly valuable method to monitor minimal residual disease (MRD) and evaluate the depth of complete response (CR) in bone marrow (BM) of multiple myeloma (MM) after therapy. However, current flow-MRD has lower sensitivity than
J. Flores-Montero, Luzalba Sanoja-Flores, B. Paiva, N. Puig, O. García-Sánchez, S. Böttcher, V. V. D. Velden, J. Perez-Moran, M. Vidriales, R. García-Sanz, Carmen Jiménez, Marcos González, J. Martínez-López, A. Corral-Mateos, G. Grigore, R. Fluxá, R. Pontes, J. Caetano, L. Sędek, M. C. Cañizo, J. Bladé, J. Lahuerta, C. Aguilar, A. Bárez, A. García-Mateo, J. Labrador, P. Leoz, C. Aguilera-Sanz, J. San-Miguel, M. Mateos, B. Durie, J. Dongen, J. Dongen, A. Órfão   +33 more
semanticscholar   +1 more source

Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?

Frontiers in Oncology, 2019
In chronic lymphocytic leukemia (CLL), there is a growing interest for minimal residual disease (MRD) monitoring, due to the availability of drug combinations capable of unprecedented complete clinical responses.
Ilaria Del Giudice, Sara Raponi, Irene Della Starza, Irene Della Starza, Maria Stefania De Propris, Marzia Cavalli, Lucia Anna De Novi, Luca Vincenzo Cappelli, Caterina Ilari, Luciana Cafforio, Anna Guarini, Robin Foà   +11 more
doaj   +1 more source

A simplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor outcome groups

Haematologica, 2009
Background Minimal residual disease is an important independent prognostic factor in childhood acute lymphoblastic leukemia. The classical detection methods such as multiparameter flow cytometry and real-time quantitative polymerase chain reaction ...
Carlos A. Scrideli, Juliana G. Assumpção, Mônica A. Ganazza, Marcela Araújo, Silvia R. Toledo, Maria Lúcia M. Lee, Elisabete Delbuono, Antonio S. Petrilli, Rosane P. Queiróz, Andrea Biondi, Marcos B. Viana, José A. Yunes, Silvia R. Brandalise, Luiz G. Tone   +13 more
doaj   +1 more source

Novel flow‐cytometric analysis based on BCD5⁺ subpopulations for the evaluation of minimal residual disease in chronic lymphocytic leukaemia [PDF]

, 2002
Karim Maloum, Laurent Sutton, Sylvie Baudet, Caroline Laurent, Patrick Bonnemye, Christian Magnac, Hélène Merle‐Béral   +6 more
openalex   +1 more source

The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients [PDF]

, 2001
Background and Objectives. Detection of PML-RAR alpha transcripts by RT-PCR is now established as a rapid and sensitive method for diagnosis of acute promyelocytic leukemia (APL), Although the majority of patients in longterm clinical remission are ...
Carrara, P, de Sousa, AB, Diamond, J, Foroni, L, Gameiro, P, Guimaraes, JE, Hoffbrand, AV, Mehta, AB, Parreira, A, Prentice, HG, Silva, AL, Vieira, S   +11 more
core